Healthcare Finance News February 13, 2020
Jeff Lagasse

Authors call for allowing Medicare to directly negotiate drug prices with manufacturers, which is currently prohibited by law.

Empowering Medicare to directly negotiate drug prices, accelerating the adoption of value-based care, using philanthropy as a catalyst for reform and expanding senior-specific models of care are among recommendations for reducing healthcare costs published in a new special report and supplement to the Winter 2019-20 edition of Generations, the journal of the American Society of Aging.

The report, “Older Adults and America’s Healthcare Cost Crisis,” includes a dozen articles by experts and leaders from healthcare, business, academia and philanthropy.

The authors examine the major drivers of the high cost of healthcare and its impact on patients, then offer solutions that can reduce...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Insurance, Market Research, Patient / Consumer, Payment Models, Pharma, Pricing / Spending, Provider, Trends, Value Based
4 top healthcare CIOs: Forbes
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development
Advancing Pharmacogenomics Education: Standardization and Opportunities in Pharmacy
RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation
STAT+: With RFK Jr. looming as health secretary, pharma execs try to project stability

Share This Article